AxoGen (NASDAQ: AXGN) reported Q1 EPS of ($0.10), $0.07 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $36.7 million versus the consensus estimate of $35.37 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.